Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Dantes, O. C. Arghir, C. Cambrea, M. Man, E. Borgazi, S. Rugina (Constanta, Cluj, Romania). The risk of tuberculosis disease among HIV infected patients after 2 years of follow up. Eur Respir J 2011; 38: Suppl. 55, 1936

Member's Comments

No comment yet.

Related content which might interest you: Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Source: Eur Respir J 2016; 48: 1420-1428 Year: 2016 The risk of tuberculosis in HIV infected in the 12 years of observation Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 Prevalence and average annual risk of TB infection at 6 & 14 years old Source: Eur Respir J 2001; 18: Suppl. 33, 144s Year: 2001 The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker Source: Eur Respir J, 50 (5) 1701414; 10.1183/13993003.01414-2017 Year: 2017 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2015; 46: 1397-1406 Year: 2015 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1594-1595 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1592-1594 Year: 2016 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 The effect of hospitalization and disease itself on smoking sessation of patients with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 155s Year: 2004 The risk of latent Mycobacterium tuberculosis infection in HIV seropositive children not BCG vaccinated Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland Source: Eur Respir J 2005; 26: Suppl. 49, 425s Year: 2005 Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010